Perioperative medicine & outcomes

Electronic Patient-Reported Symptoms After Ambulatory Cancer Surgery

JAMA SurgPublished Retrospective cohort study

Authors' conclusion

Defining detailed postoperative symptom burden through this analysis provides valuable data to inform further implementation and maintenance of RSM programs in surgical oncology patients.

Study context

Population
Patients undergoing ambulatory prostatectomy, nephrectomy, mastectomy, hysterectomy or thyroidectomy at the Josie Robertson Surgery Center, Memorial Sloan Kettering Cancer Center, September 2016 to June 2022, with remote symptom monitoring via an ePRO platform (Recovery Tracker) for 10 days after surgery10,814 responded
Participants
12,433 patients
Outcome
Symptom severity and interference by postoperative day and procedure
Follow-up
10 days after surgery
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Postoperative symptom burden
Fatigue reported (rarely severe)
6120 patients (57%)
Very severe pain
324 of 10 814 (3%)
Very severe fatigue
106 of 10 814 (1%)
Severe or very severe maximum pain after nephrectomy
92 of 332 [28%]
Severe or very severe maximum pain after mastectomy with reconstruction
817 of 3322 [25%]
Severe or very severe maximum pain after prostatectomy
744 of 3543 [21%]
Nausea on multiple days
1485 of 9300 (16%)
Vomiting
139 of 10 812 [1%]
Temperature higher than 38 °C
740 of 10 812 (7%)
Severe or very severe shortness of breath
125 of 10 813 (1%)

Observational data: associations, not effects.

Further findings

Survey completion

Surveys assigned
110 936
Survey response rate
87%
Median (IQR) surveys submitted
7 (4-8)
Median (IQR) minutes per assessment
1.7 (1.2-2.5)

Original publication

Electronic Patient-Reported Symptoms After Ambulatory Cancer Surgery. JAMA Surg. Published 1 May 2024. doi:10.1001/jamasurg.2024.0133

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.